372 related articles for article (PubMed ID: 9453335)
1. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
Kassab S; Miller MT; Novak J; Reckelhoff J; Clower B; Granger JP
Hypertension; 1998 Jan; 31(1 Pt 2):397-402. PubMed ID: 9453335
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension.
Kassab S; Novak J; Miller T; Kirchner K; Granger J
Hypertension; 1997 Sep; 30(3 Pt 2):682-6. PubMed ID: 9323005
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
4. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
Barton M; d'Uscio LV; Shaw S; Meyer P; Moreau P; Lüscher TF
Hypertension; 1998 Jan; 31(1 Pt 2):499-504. PubMed ID: 9453352
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelin-A receptor antagonism on bilateral renal function in renovascular hypertensive rats.
Kassab S; Hamdy H; AbdulGhaffar T; Granger JP
Fundam Clin Pharmacol; 2001 Dec; 15(6):379-85. PubMed ID: 11860525
[TBL] [Abstract][Full Text] [Related]
6. Salt-induced hypertension in Dahl salt-sensitive rats. Hemodynamics and renal responses.
Simchon S; Manger WM; Carlin RD; Peeters LL; Rodriguez J; Batista D; Brown T; Merchant NB; Jan KM; Chien S
Hypertension; 1989 Jun; 13(6 Pt 1):612-21. PubMed ID: 2525523
[TBL] [Abstract][Full Text] [Related]
7. Induction of P4504A activity improves pressure-natriuresis in Dahl S rats.
Alonso-Galicia M; Frohlich B; Roman RJ
Hypertension; 1998 Jan; 31(1 Pt 2):232-6. PubMed ID: 9453308
[TBL] [Abstract][Full Text] [Related]
8. Role of neuronal nitric oxide synthase in Dahl salt-sensitive hypertension.
Tan DY; Meng S; Manning RD
Hypertension; 1999 Jan; 33(1 Pt 2):456-61. PubMed ID: 9931147
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension.
Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Maeda S; Miyauchi T; Nishikibe M
Hypertension; 1999 Sep; 34(3):514-9. PubMed ID: 10489403
[TBL] [Abstract][Full Text] [Related]
10. Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.
Samad MA; Kim UK; Kang JJ; Ke Q; Kang PM
PLoS One; 2015; 10(3):e0121664. PubMed ID: 25775254
[TBL] [Abstract][Full Text] [Related]
11. Renal interstitial Ca2+ during sodium loading of normotensive and Dahl-salt hypertensive rats.
Palmer CE; Rudd MA; Bukoski RD
Am J Hypertens; 2003 Sep; 16(9 Pt 1):771-6. PubMed ID: 12944037
[TBL] [Abstract][Full Text] [Related]
12. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
Patel A; Layne S; Watts D; Kirchner KA
Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D(3) receptors and salt-dependent hypertension.
Luippold G; Zimmermann C; Mai M; Kloor D; Starck D; Gross G; Mühlbauer B
J Am Soc Nephrol; 2001 Nov; 12(11):2272-2279. PubMed ID: 11675403
[TBL] [Abstract][Full Text] [Related]
14. Vasoconstrictors and renal protection induced by beta 1-selective adrenoceptor antagonist bisoprolol.
Uehara Y; Takada S; Hirawa N; Kawabata Y; Ohshima N; Numabe A; Ishimitsu T; Goto A; Yagi S; Omata M
J Cardiovasc Pharmacol; 1994 Jun; 23(6):897-906. PubMed ID: 7523781
[TBL] [Abstract][Full Text] [Related]
15. Effects of lipid-lowering agents in the Dahl salt-sensitive rat.
Wilson TW; Alonso-Galicia M; Roman RJ
Hypertension; 1998 Jan; 31(1 Pt 2):225-31. PubMed ID: 9453307
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
17. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
[TBL] [Abstract][Full Text] [Related]
18. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats.
Kataoka H; Otsuka F; Ogura T; Yamauchi T; Kishida M; Takahashi M; Mimura Y; Makino H
Am J Hypertens; 2001 Mar; 14(3):276-85. PubMed ID: 11281241
[TBL] [Abstract][Full Text] [Related]
20. Prevention of the progression of renal injury in diabetic rodent models with preexisting renal disease with chronic endothelin A receptor blockade.
Spires D; Poudel B; Shields CA; Pennington A; Fizer B; Taylor L; McPherson KC; Cornelius DC; Williams JM
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F977-F985. PubMed ID: 29846112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
